SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

13 Jun 2013 17:29

RNS Number : 0287H
Caledonia Investments PLC
13 June 2013
 



CALEDONIA INVESTMENTS PLC - GRANT OF SHARE OPTIONS AND DEFERRED BONUS AWARDS

Caledonia Investments plc ("Caledonia") announces that on 12 June 2013 the following nil-cost options and deferred share awards over ordinary 5p shares in Caledonia were granted to executive directors under the Caledonia Investments 2011 Performance Share Scheme (the "Performance Share Scheme") and the Caledonia Investments 2011 Deferred Bonus Plan (the "Deferred Bonus Plan"). The company's share price used to determine the number of Performance Share Scheme and Deferred Bonus Plan awards was 1802p.

Executive Director

No. of shares over which Performance Share Scheme nil-cost options granted

No. of shares subject to Deferred Bonus Plan awards

Compulsory deferral

Matching shares

Total

J M B Cayzer-Colvin

20,565

7,986

7,986

15,972

S A King

24,320

9,444

9,444

18,888

W P Wyatt

34,275

13,310

13,310

26,620

Subject to the rules of the Performance Share Scheme, nil-cost options are exercisable between three and ten years after the date of grant. Subject to the rules of the Deferred Bonus Plan, deferred share awards vest three years after award.

The total number of awards held by the above-named executive directors of Caledonia under the Performance Share Scheme, the Company's executive share option schemes and its deferred bonus plans following these nil-cost option grants and deferred share awards are as follows:

Executive Director

Total no. of shares held under option under the Performance Share Scheme

Total no. of shares held under option under the executive share option schemes

Total deferred bonus plan share awards

Compulsory deferral

Voluntary deferral

Matching shares

Total

J M B Cayzer-Colvin

71,571

32,786

10,321

0

10,321

20,642

S A King

84,641

0

12,666

0

12,666

25,332

W P Wyatt

119,286

51,286

17,545

0

17,545

35,090

 

Enquiries:

Mrs K M Burwood

Deputy Company Secretary

Caledonia Investments plc + 44 20 7802 8080

13 June 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSFWFMDFDSEEM
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.